Neurinnov is a neurotechnology company developing implantable stimulators to restore function in people with severe paralysis. Its main focus is upper-limb neuroprosthetics for individuals with tetraplegia, using selective nerve stimulation to reanimate hand and finger movements. The company’s technology is designed to improve functional recovery by enabling more precise control than conventional stimulation approaches.

The platform uses multi-electrode implants and current-steering methods to target specific nerve fibers within peripheral nerves. This allows more selective muscle activation and supports finer, more coordinated movement patterns. By pairing implantable hardware with external control systems, the approach is intended to translate user intent into practical grasp and release functions.

Neurinnov’s initial application is in spinal cord injury, particularly for restoring hand use in people with tetraplegia. Over time, the technology could also have relevance in other forms of neuromuscular impairment where precise peripheral nerve stimulation may improve motor function. Its work sits within a broader effort to use implantable neurotechnology to restore meaningful movement and autonomy after paralysis.